Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
Cellular models of organs have been used to investigate mechanisms of disease. Here the authors generate a human alpha synuclein-induced brain-chip model that recapitulates blood-brain barrier dysfunction, as a potential testing platform for novel therapeutics in Parkinson’s disease.
Guardado en:
Autores principales: | Iosif Pediaditakis, Konstantia R. Kodella, Dimitris V. Manatakis, Christopher Y. Le, Chris D. Hinojosa, William Tien-Street, Elias S. Manolakos, Kostas Vekrellis, Geraldine A. Hamilton, Lorna Ewart, Lee L. Rubin, Katia Karalis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c79c98786c94d82a820ab3e121c9759 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease.
por: Elisabeth Kapaki, et al.
Publicado: (2013) -
A Novel Microphysiological Colon Platform to Decipher Mechanisms Driving Human Intestinal PermeabilitySummary
por: Athanasia Apostolou, et al.
Publicado: (2021) -
Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts
por: Timo Strohäker, et al.
Publicado: (2019) -
Direct visualization of CHIP-mediated degradation of alpha-synuclein in vivo: implications for PD therapeutics.
por: Hemi Dimant, et al.
Publicado: (2014) -
Impairment of mitochondria in adult mouse brain overexpressing predominantly full-length, N-terminally acetylated human α-synuclein.
por: Theodore A Sarafian, et al.
Publicado: (2013)